Skip to main content

and
  1. Article

    Open Access

    A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503)

    The Notch signalling pathway has been implicated in tumour initiation, progression, angiogenesis and development of resistance to vascular endothelial growth factor (VEGF) targeting, providing a rationale for ...

    S Sahebjam, P L Bedard, V Castonguay, Z Chen, M Reedijk, G Liu in British Journal of Cancer (2013)

  2. Article

    Open Access

    Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence score

    Immunohistological assessment of Ki 67 expression is less expensive than Oncotype Dx, which is currently used to identify patients with lymph node-negative breast cancer, who will benefit from adjuvant chemoth...

    S Sahebjam, R Aloyz, D Pilavdzic, M-L Brisson, C Ferrario in British Journal of Cancer (2011)